This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 May-Jun;12(3):167-9.

doi: 10.1097/00130404-200605000-00001.

Granulocyte colony stimulating factor for mucositis during post-operative radiotherapy

Janice Gabrilove¹

Affiliations

Affiliation

¹ Division of Hematology and Medical Oncology, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. janice.gabrilove.mssm.edu

PMID: 16803671
DOI: 10.1097/00130404-200605000-00001

Editorial

Granulocyte colony stimulating factor for mucositis during post-operative radiotherapy

Janice Gabrilove. Cancer J. 2006 May-Jun.

. 2006 May-Jun;12(3):167-9.

doi: 10.1097/00130404-200605000-00001.

Author

Janice Gabrilove¹

Affiliation

¹ Division of Hematology and Medical Oncology, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. janice.gabrilove.mssm.edu

PMID: 16803671
DOI: 10.1097/00130404-200605000-00001

No abstract available

PubMed Disclaimer

Comment on

Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer.
Su YB, Vickers AJ, Zelefsky MJ, Kraus DH, Shaha AR, Shah JP, Serio AM, Harrison LB, Bosl GJ, Pfister DG. Su YB, et al. Cancer J. 2006 May-Jun;12(3):182-8. doi: 10.1097/00130404-200605000-00005. Cancer J. 2006. PMID: 16803675 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.